en

PRODUCT DETAIL

Rubraca 250 mg filmom obalené tablety

Code 8166C
MA number EU/1/17/1250/002
Product Form: tbl flm 60x250 mg (fľ.HDPE)
MA Status: Ex - Conditional centralised marketing authorisation
Type of procedure: EU
MAH, country: Pharmaand GmbH, Austria
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors
L01XK03 Rucaparib
Shelf life: 48
Container: bottle HDPE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 24.05.2018
Validity: 09.11.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 14.11.2022
eu-flag.png sk-flag.png